Dear Colleagues,

The genus Vibrio comprises Gram-negative bacteria that are halophilic, mesothermal, and acid-intolerant. They get their name from the fact that they frequently have a short, curved shape. They thrive in estuaries, bays, and coastal waters, and several species of this group are widely distributed in seawater and marine animals. Several vibrios are major pathogens that not only threaten fish and the aquaculture industry but also pose a significant health risk to humans, for example, Vibrio vulnificus. Acute gastroenteritis, sepsis, and necrotizing fascitiis can occur when people eat or come into contact with vibrios, and vibrio disease incidence is on the rise, due to global warming, emissions, and antibiotic misuse. Cephalosporin, tetracycline, fluoroquinolone, or combinations of medications are currently the most popular treatments for vibrio infections. However, several studies have shown that vibrios have developed drug resistance to these current treatment options. As global drug resistance spreads, future marine vibrio bacteria may develop drug resistance to the above antibiotics, posing a greater threat to human health. Until now, drug resistance research has mainly concentrated on medical care or domestic research in different countries, and research collaboration on drug resistance in the seawater environment has not yet been completed. To deal with a potential future crisis of marine vibrio resistance, scientists from various fields around the world must work together to overcome this dilemma.

Prof. Dr. Darrell Jay Grimes
Guest Editor
Dr. Shuo Shen
Co-Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• vibrio disease
• antibiotic resistance
• vibrio necrotizing fasciitis
• marine microbiology